Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Effects of Clozapine for Non-Treatment-Resistant Patients with Schizophrenia|
|Citation:||Psychiatric Services, 1999; 50(1):101-103|
|Publisher:||AMER PSYCHIATRIC PUBLISHING, INC|
|Abstract:||Clozapine is generally used for patients meeting criteria for treatment resistance. In this study clozapine was given to 19 patients with schizophrenia who did not meet these criteria and whose symptoms were mild to moderate in severity. Clozapine was associated with significant improvement in positive and negative symptoms and quality of life. A more modest improvement on a range of tests of cognitive functioning was also noted. These results suggest that consideration should be given to broadening the usual criteria for patients' eligibility for clozapine treatment.|
|Keywords:||Humans; Clozapine; Antipsychotic Agents; Treatment Outcome; Drug Administration Schedule; Schizophrenia; Psychiatric Status Rating Scales; Dose-Response Relationship, Drug; Quality of Life; Adult; Female; Male|
|Appears in Collections:||Psychiatry publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.